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A large component of the whole-cell currents through Ca2’ channels in bovine adrenomedullary chromaffi cells has been shown to be insensitive 
to both L-type and N-type Ca2+ channel blockers, suggesting the existence of a third type of Ca2’ channel. In the present paper, w-agatoxin-IVA 
(AgTx), a selective blocker of P-type Ca” channels in mammalian eurons, has been used to investigate the presence of this subtype of Ca*+ channel 
in bovine chromaffin cells. Barium currents (Z& through Ca*+ channels were recorded in whole-cell patch-clamped bovine chromaffin cells. ZBa 
was blocked by AgTx in a dose-dependent and irreversible manner. At the maximal concentration used (1 PM), AgTx inhibited Za, by 49.5 f 3%. 
Such a blockade was also present when bovine chromathn cells were pretreated with 10,uM furnidipine, a novel 1,Cdihydropyridine L-type channel 
blocker, and after treatment with 1 PM of the N-type channel blocker, w-conotoxin GVIA (CgTx). A combination of these three types of Ca2+ 
channel blockers suppressed the macroscopic Ba*’ currents by 88%. We conclude that bovine chromaffin cells, in addition to N- and L-type Ca2’ 
channels, possess a P-like component in their whole-cell currents through the Ca*’ channels. 
P-type Ca*’ channel; Chromaffin cell; w-Agatoxin-IVA 
1. INTRODUCTION 
Among the different subtypes of voltage-dependent 
Ca2’ channels that have been described in neurons [ 1,2], 
studies in bovine chromaffin cells seem to indicate that 
only high voltage-activated Ca2+ channels (HVA; L-and 
N-type) are present, while low voltage-activated (LVA; 
T-type) Ca2’ channels do not appear to be present in 
these cells [3-61. Recent studies on whole-cell Ca2+ cur- 
rents in bovine chromaffin cells have shown that these 
cells contain dihydropyridine (DHP)-sensitive [3,7] as 
well as w-conotoxin GVIA (CgTx)-sensitive compo- 
nents [8-lo], but a large third component, DHP- and 
CgTx-resistant is always present. The pharmacology of 
this channel remains unknown. 
On the other hand, a new class of voltage-sensitive 
Ca2’ channel, P-type, has been described in neurons and 
characterized by its sensitivity to the toxin fraction 
(FTX) of the poison from the funnel web spider Agelen- 
opsis aperta [ 1 I] and to the purified peptide o-agatoxin- . 
IVA (AgTx) [12,13]. By using FTX or its synthetic ana- 
logue (sFTX 3:3), on catecholamine secretion experi- 
ments [14] and on whole-cell recordings of Ba2’ currents 
[lo], the existence of this type of Ca2’ channels in bovine 
chromaffi cells has recently been suggested. Because 
the specificity of sFTX 3:3 to block only P-type Ca2+ 
channels has recently been challenged [15], we have at- 
tempted to characterize the presence of P-type Ca2+ 
channels in bovine chromaffin cells by using the peptide 
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fraction AgTx from the funnel web spider venom, which 
specifically blocks this type of voltage-dependent Ca2’ 
channels in neurons [12,13]. 
2. MATERIALS AND METHODS 
Chromafi cells were enzymatically isolated from adult bovine 
adrenal medullae following methods previously described [ 161. Cells 
were suspended in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% foetal calf serum, 50 IU.ml-’ penicillin and 
5Ogg. ml-’ streptomycin, at a density of 50 x 10’ cells~rn-‘. Cells were 
plated on glass coverslips and maintained in an incubator under an 
atmosphere of 95% air/58 CO, at 37°C. Experiments were performed 
in cells from 2 to 8 days in culture. All experiments were done at room 
temperature (22-25°C). 
Ba2+ currents in chromtin cells were recorded using the whole-cell 
configuration of the patch-clamp technique [17]. Coverslips contain- 
ing the cells were placed on an experimental chamber mounted on the 
stage of a Nikon Diaphot inverted microscope. The chamber was 
continuously perfused with a control Krebs solution containing (in 
mM): 145 NaCl, 1 MgCl,, 2 CaCl,, 10 HEPESZNaOH, 0.002 tetro- 
dotoxin (TTX), pH 7.4. For current recordings, 10 mM Ba*’ (instead 
of 2 mM Ca*+) was used as the charge carrier. Cells were dialyzed with 
an intracellular solution containing (in mM): 10 NaCl, 100 CsCl, 20 
TEA.Cl, 5 MgATP, 14 EGTA, 20 HEPEYCsOH, pH 7.2. 
Whole-cell recordings were made with fire-polished electrodes (re- 
sistance 2-5 MR) mounted on the headstage of a DAGAN 8900 
patch-clamp amplifier, allowing cancellation of capacitative transient 
and compensation of series resistance. A Labmaster data acquisition 
and analysis board and a 386-based microcomputer with pCLAMP 
software (Axon Instruments, Inc.) were used to acquire and analyze 
the data. Solutions were exchanged using a multibarreled concentra- 
tion-clamp device, the common outlet of which was placed within 100 
pm of the cell to be patched. 
DMEM, fetal calf serum, penicillin and streptomycin were pur- 
chased from Gibco, Madrid, Spain. TTX and CgTx were purchased 
from Sigma, Madrid, Spain. AgTx was purchased from SMA (Scien- 
tific Marketing Associates, Bamet, Herts, EN5 5SU, UK). Furni- 
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Fig. 1. Whole-cell peak current-voltage relationship for I,, recorded in a patch-clamped bovine chromaffin cell before and after the superfusion 
with an extracellular solution containing AgTx (1 PM). Currents were elicited by 50 ms depolarizing pulses from a holding potential of -70 mV 
applied at 0.2 Hz in 10 mV steps. Current traces were obtained before (control) and after superfusion of the cell with AgTx (1 PM). Each 
concentration of toxin was present at least 2 min before the application of the depolarizing pulse. Insets show original current traces recorded at 
the indicated test potentials. 
dipine was supplied by Alter S.A., Madrid, Spain. sFTX was supplied 
by Eli-Lilly, UK. Other chemicals were obtained either from Sigma 
or Merck, Madrid, Spain. 
3. RESULTS 
3.1. AgTx blocks a component of the whole-cell Bd’ 
current 
Ba2+ currents were elicited by 50 ms depolarizing 
pulses applied from a holding potential of -70 or -80 
mV in 10 mV steps. Other ionic currents were sup- 
pressed by dialyzing the chromafi cells with the Cs’- 
based intracellular solution and by superfusing them 
with an extracellular solution containing TTX (2 PM). 
Superfusion of the cells with an extracellular solution 
containing increasing concentrations of AgTx led to a 
dose-dependent decrease of the barium current. At the 
concentration of 0.3 ,uM, Z,, was inhibited 25 ? 4% 
(n = 7), from an average control value of 619 + 85 pA, 
to 463 f 67 pA. At 1 PM, the current was further de- 
creased to 49.5 f 3% (n = 17; Fig. 1). Not all cells re- 
sponded to AgTx with a similar degree of blockade, 
suggesting that different cells contain different propor- 
tions of the various subpopulations of Ca” channels. 
The effects of AgTx were irreversible upon washing 
out (5-10 min) the toxin from the extracellular medium, 
and were not accompanied by significant alterations of 
the voltage-dependence of ZBa (Fig. 1). AgTx suppressed 
ZBa t all potentials tested without significantly shifting 
the I-Vcurve and without appreciable alterations in the 
activation and inactivation kinetics of the current (Fig. 
1, insets). 
3.2. Effects of AgTx in cells pretreated with other Cd’ 
channel blockers 
In order to test the specificity of AgTx, experiments 
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were performed in chromaffin cells pretreated with fur- 
nidipine, a specific DHP L-type Ca” channel blocker 
[18] or CgTx, a N-type Ca2’ channel blocker. In these 
experiments, AgTx was applied either before or after 
the other blockers. Fig. 2 shows the time course for the 
blocking effects observed in a cell upon superfusion 
with an extracellular solution containing CgTx (1 PM). 
Under these conditions ZBa was blocked 43 f 3% 
(n = 31). Upon washing out CgTx, blockade did not 
reverse. Once the maximum blockade of CgTx was 
reached and reversibility of this blockade was not ob- 
served, AgTx (1 PM) was added to the perfusion solu- 
tion; an additional blockade of ZBa could then be appre- 
ciated (Fig. 2). As seen with CgTx, washout of AgTx did 
not result in recovery of the current. Further addition 
of furnidipine (10 PM) accounted for an additional 
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Fig. 2. Time course for the blocking effects of CgTx (1 PM), AgTx 
(1 PM) and furnidipine (10 PM) on la.. Currents were elicited by 50 
ms depolarizing pulses to 0 mV from a holding potential of -80 mV. 
applied at 20 s intervals (see protocol at inset). 
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Fig. 3. Effects of different types of Ca” channel blockers on chro- 
maffin cell macroscopic Ba” currents. Depolarizing pulses were ap- 
plied in the absence (control) and the presence of AgTx (1 PM), CgTx 
(1 ,uM) and furnidipine (10 PM). ZBs was elicited as in Fig. 1. The inset 
shows capacitance and linear leak subtracted current traces elicited by 
a 50 ms test pulse to 0 mV from a holding potential of -80 mV, under 
the different perfusion conditions indicated in the figure. 
blockade of the small current left. The effects of furni- 
dipine were reversible upon removing the DHP from the 
perfusion solution. In some cells, a small current re- 
mained with all three blockers present. Averaged data 
from experiments in which combination of these three 
types of Ca*’ channel blockers were used show 88 * 2% 
blockade (n = 14). 
The effects of the combination of these Ca2’ channel 
blockers were also studied on the availability of the 
channels. Fig. 3 shows the effects of AgTx, CgTx and 
furnidipine on the peak current-voltage relationships 
obtained both in the absence or upon application of the 
blockers. No significant shift of the curves were ob- 
served with any of the blockers used. In this cell, AgTx 
was applied before CgTx, and a similar degree of block- 
ade was observed. Maximal block by AgTx did not 
prevent further inhibition by additional application of 
CgTx and furnidipine, showing that N- and L-type cur- 
rents remained intact after AgTx treatment. 
3.3. Speczjicity of AgTx vs sFTX 
Experiments were performed to test whether AgTx 
and the polyamine sFTX were both acting on the same 
type of Ca*+ channels. For these experiments we took 
advantage of the reversibility of the sFTX blocking ef- 
fects of whole cell currents previously described [lo] 
versus the irreversibility of the blocking effects of AgTx 
described above. We were expecting that if both toxins 
were acting on the same target, binding of sFTX could 
prevent the binding of AgTx, protecting the AgTx ‘re- 
ceptor’ against irreversible blockade. 
Fig. 4 shows a representative xperiment where su- 
perfusion of a chromaffin cell with a solution containing 
both sFTX (1 mM) and AgTx (1 PM) led to the ex- 
petted 50% decrease of IBa. These blocking effects had 
a fast onset, in accordance with the fast blocking effects 
of sFTX [lo] and in opposition to the slow effect ob- 
served when only AgTx was perfused (Fig. 2). When 
toxins were removed from the extracellular solution, 
blockade was reversed. Further addition of AgTx led to 
the slow and irreversible effect of this toxin. These re- 
sults suggest hat addition of sFTX prevents the binding 
of AgTx to its ‘receptor’. 
In these experiments, another interesting feature of 
sFTX was observed. Once the maximum effects of a 
supramaximal concentration of AgTx were reached, 
and hence AgTx-sensitive Ca*+ channels were fully 
blocked, application of sFTX, either alone or in combi- 
nation with AgTx, led to a further decrease of IBa (Fig. 
4), suggesting that sFTX, in addition to the blockade of 
P-Type Ca2+ channels, could block another component 
of the whole-cell currents through Ca*’ channels. This 
add evidence supporting the suspected unspecificity of 
sFTX to only block the P-type Ca*+ channels [15]. 
4. DISCUSSION 
In contrast to cat chromathn cells where an L-type 
Ca2+ channel seems to dominate the control of catechol- 
amine release, the bovine chromaffin cell offers a more 
complex picture. Early experiments on Ca*+ uptake into 
K’-depolarized bovine chromaffin cells already sug- 
gested that extracellular Ca*’ could enter the cells 
through both DHP- as well as CgTx-sensitive pathways 
[19]. In addition, a DHP- and CgTx-resistant compo- 
nent of Ca2+ uptake was also described [20]. The exis- 
tence of different subtypes of Ca2’ channels was corrob- 
orated through the recording of whole-cell and single 
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Fig. 4. Time course for the blocking effects of sFTX (1 mM) and AgTx 
(1 PM) on Z& When indicated (arrows) toxins were applied (either 
alone or in combination) or removed from the extracellular solution 
(washout). Cell was held at -70 mV and 50 ms pulses to 0 mV were 
applied at 10 s intervals. 
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Ca2’ channel activity [3-61. However, a third type of 
HVA Ca2+ channel, insensitive to both DHPs and CgTx 
seemed to be present in bovine cells; its identity re- 
mained unknown. The results of this study strongly 
suggest hat the third component of the whole-cell ZBa 
is certainly associated to a P-type-like Ca2+ channel. The 
following arguments upport this contention. (i) AgTx 
halves ZBa in an irreversible manner. This behaviour 
reminds the effects of the toxin on neurones endowed 
with P-type Ca2+ channels [12,13]. (ii) A common site 
for sFTX and AgTx exists in bovine chromafin cells, 
as proven by the fact that sFTX prevents the irreversible 
blockade of ZBa by AgTx; though apparently less spe- 
cific, sFTX is however being considered as a P-type 
channel blocker [ll]. (iii) In Purkinje neurons, which 
only contain P-type Ca2+ channels, AgTx fully block 
them at concentrations below 300 nM [12,13]. It should 
be noted that in contrast with Purkinje cells, higher 
concentrations of AgTx were required in order to block 
the DHP- and CgTx-resistant component of the whole 
cell Ba2’ current in bovine chromaffin cells. Two rea- 
sons could be argued to explain this difference: first, we 
are using a synthetic batch of the toxin instead of the 
natural toxin used in Purkinje experiments [12,13] and 
its affinity for the receptor could be different. Second, 
a non P-type Ca” channel that binds AgTx with lower 
affinity than the Purkinje cell might exist in bovine chro- 
maffin cells. Therefore, we will refer to this component 
as a P-type-like Ca2’ channel. (iv) After treating bovine 
chromafhn cells with supramaximal AgTx concentra- 
tions (1 PM), CgTx- and DHP-sensitive components of 
ZBa still remained. And vice versa, after using supramax- 
imal concentrations of CgTx to block N channels, or 
furnidipine to block L channels, a large component of 
ZBa sensitive to AgTx still remained. 
We conclude that P-type-like Ca2’ channels, similar to 
those described in neurons are present in cultured bovine 
chromaffin cells. CgTx does not block catecholamine 
release in response to chromaffin cell stimulation with 
acetylcholine or high K+ concentrations, and DHPs an- 
tagonists block only partially such response [21]. It is 
plausible that P-like Ca2’ channels strategically located 
near the plasmalemmal exocytotic sites might play an 
important role in regulating the access of extracellular 
Ca2’ to the intracellular secretory machinery. 
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